+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Benznidazole in the primary chemoprophylaxis of the reactivation of Chagas' disease in chronic chagasic patients using corticosteroids at immunosuppressive doses: is there sufficient evidence for recommending its use?



Benznidazole in the primary chemoprophylaxis of the reactivation of Chagas' disease in chronic chagasic patients using corticosteroids at immunosuppressive doses: is there sufficient evidence for recommending its use?



Revista Da Sociedade Brasileira de Medicina Tropical 33(1): 83-85



There is evidence that trypanosomicide drugs prevent the parasitological reactivation of Chagas' disease in patients under corticosteroid therapy. On the other hand there are few reports of clinical reactivation of this disease associated with the use of these immunosuppressive drugs. Primary chemoprophylaxis with trypanosomicide in this situation should not be recommended before being assessed by a randomized controlled trial.

(PDF emailed within 1 workday: $29.90)

Accession: 045361698

Download citation: RISBibTeXText

PMID: 10881124



Related references

Primary chemoprophylaxis with benznidazole in the reactivation of Chagas' disease in chronic chagasic patients under immunosuppressive corticosteroid therapy: is there sufficient evidence for its recommendation?. Revista da Sociedade Brasileira de Medicina Tropical 33(1): 83-85, 2000

Benznidazole as a prophylactic drug to prevent reactivation in chronic chagasic patients treated with corticoids for associated diseases. Revista da Sociedade Brasileira de Medicina Tropical 32(5): 475-482, 1999

Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole. Transplant Infectious Disease 1(2): 135-137, 2001

Reactivation of chronic Chagas disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole. Transplant Infectious Disease 1(2): 135-137, 1999

Fatal evolution of Chagas'disease/Aids co-infection: diagnostic difficulties between myocarditis reactivation and chronic chagasic myocardiopathy. Revista Da Sociedade Brasileira de Medicina Tropical 42(2): 199-202, 2009

Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease causing cardiac disease in three patients. Clinical Infectious Diseases 26(1): 177-179, 1998

Reactivation of Chagas' disease sucessfully treated with benznidazole in a patient with acquired immunodeficiency syndrome. Memorias do Instituto Oswaldo Cruz 88(3): 493-496, 1993

Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country. Journal of Antimicrobial ChemoTherapy 65(8): 1759-1764, 2010

Use of thioctic acid to prevent the toxic effects of benznidazole in patients with chronic Chagas' disease. Medicina, Argentina 43(3): 285-290, 1983

Comparison of mortality during five years follow-up in patients with chronic Chagas' disease, with and without benznidazole treatment. Revista de Patologia Tropical 27(Supplement): 29-31, 1998

Longitudinal study of the persistence of the therapeutic action of nifurtimox and benznidazole in patients with chronic chagas disease. Boletin Chileno de Parasitologia 36(3-4): 59-62, 1981

Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. American Heart Journal 127(1): 151-162, 1994

Treatment of chronic Chagas' disease benznidazole: Clinical and serologic evolution of patients with long-term follow-up. American Heart Journal 127(1): 151-162, 1994

Toxic Profile of Benznidazole in Patients with Chronic Chagas Disease: Risk Factors and Comparison of the Product from Two Different Manufacturers. Antimicrobial Agents and ChemoTherapy 59(10): 6125-6131, 2016

Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: When available options fail. Clinical Microbiology and Infection, 2018